<DOC>
	<DOC>NCT00820027</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo and ibuprofen in the treatment of postoperative pain associated with unilateral total knee replacement surgery.</brief_summary>
	<brief_title>Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Is in generally good health and is scheduled to have a total knee replacement Is allergic, intolerant to, or has a history of a significant clinical or laboratory adverse experience associated with etoricoxib or other cyclooxygenase2 (COX2) inhibitors/nonsteroidal antiinflammatory drugs (NSAIDs), ibuprofen, morphine, or oxycodone, or has hypersensitivity to aspirin, or other NSAIDs Has uncontrolled hypertension Is currently a user of any illicit drugs, or has a history of drug or alcohol abuse within the past 5 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>